Renalytix (LON:RENX) Trading 9.7% Higher – What’s Next?

Shares of Renalytix Plc (LON:RENX) shot up 9.7% during mid-day trading on Tuesday . The company traded as high as GBX 8.50 ($0.11) and last traded at GBX 8.50 ($0.11). 695,444 shares traded hands during trading, an increase of 61% from the average session volume of 431,612 shares. The stock had previously closed at GBX 7.75 ($0.10).

Renalytix Stock Performance

The firm’s 50 day simple moving average is GBX 7.70 and its 200 day simple moving average is GBX 11.44. The company has a current ratio of 0.53, a quick ratio of 2.42 and a debt-to-equity ratio of 173.95. The firm has a market cap of £14.10 million, a PE ratio of -32.29 and a beta of 2.10.

Insider Activity

In other news, insider James Renwick McCullough purchased 53,300 shares of the company’s stock in a transaction that occurred on Thursday, December 5th. The shares were bought at an average price of GBX 8 ($0.10) per share, for a total transaction of £4,264 ($5,435.31). Also, insider Christopher H. B. Mills sold 83,696 shares of Renalytix stock in a transaction dated Monday, October 7th. The shares were sold at an average price of GBX 8 ($0.10), for a total transaction of £6,695.68 ($8,534.96). Insiders own 35.74% of the company’s stock.

About Renalytix

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.